Years of research in the cancer field has culminated in Vaxenta's discovery and development of an innovative immunotherapeutic vaccine: XenUvaX. This revolutionary cancer treatment can benefit patients due to its unique strategy focused on re-awakening the immune system. Although still in pre-clinical trials, XenUvaX has been proven effective in training the immune system of rodent species to recognize and target foreign markers, called antigens, presented on cancer cells. Additionally, XenUvaX stimulates the immune system to detect cancer mutations, evasion mechanisms, and growth factors eliminating outlets for the cancer to evade the vaccine's effect.
Murine studies have demonstrated efficacy in both colon and melanoma cancer models. Vaxenta plans to target melanoma as the initial indication for XenUvaX; however, the research will be expanded to include prostate, ovarian, bladder, lung and breast cancer. Vaxenta aims to develop a comprehensive solution through which the body is equipped with adequate resources to combat multiple forms of cancer.
The founder and CEO of Vaxenta Biotechnologies,
The PCT application will allow the company to enforce its intellectual property rights in over 140 countries as well as help to facilitate its international expansion within the near future. Vaxenta's goal is to develop its unique immunotherapeutic vaccine to safely recognize, fight and prevent cancer with a treatment that will be readily accessible worldwide in the near future. With safety in mind, Vaxenta plans to continue to innovate in the space of immunotherapy and provide a natural alternative to current chemical treatments. www.vaxenta.comwww.twitter.com/Vaxentawww.facebook.com/pages/Vaxenta-Biotechnologies/214599478711139 Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20131231005298/en/
Keywords for this news article include: Genetics, Oncology, Treatment, Cancer Vaccines, Vaxenta Biotechnologies, Clinical Trials and Studies.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Obama Administration Releases Proposal to Regulate For-Profit Colleges
- Elizabeth Vargas' Husband Marc Cohn Addresses Rumors
- Keurig Adds Peet's coffee, Alters Starbucks deal
- Quiznos Files for Chapter 11
- SoCalGas Reaches Record Spend on Diversity Suppliers
- Vybz Kartel Convicted of Murder
- Is Malaysian Airlines Flight 370 in Andaman Sea?
- Koch Brothers Step up Anti-Obamacare Campaign
- U.S. Consumer Sentiment Falls in Early March
- U.S. to Relinquish Gov't Control Over Internet